6 ways to help validate your nutritional products
"Validated," "scientifically proven," "clinically tested": these phrases appear constantly in nutritional marketing. Their meaning varies considerably depending on the method behind them. Understanding which approach is right for your product (and your resources) is the starting point for building a credible evidence base.
Here are six ways to generate that evidence, each with distinct strengths and limitations.
1. Consumer insights
Surveys, interviews, and feedback from real customers about their experience with a product. Fast, relatively low-cost, and directly relevant to how the market perceives your offering.
- Strengths: Reflects actual usage, informs marketing, quick to run
- Limitations: Self-reported data carries bias, lacks scientific control, consumer perception shifts over time
2. Real-world evidence (RWE)
Data collected from people using the product in their everyday lives, rather than under controlled trial conditions. Includes ePRO, wearable data, app-based diaries, and remote biomarker kits.
- Strengths: Captures real behaviour and variability, scalable, increasingly recognised by regulators, produces long-term data
- Limitations: Unstructured data, harder to control for confounders, selection bias is a real risk
3. Randomised controlled trials (RCTs)
The gold standard for establishing cause and effect. Participants are randomised to treatment or control, and outcomes are compared under controlled conditions.
- Strengths: Strong evidence of efficacy, reduces bias, required for regulatory claims in many categories
- Limitations: Expensive and time-consuming, often reflects a narrow population, strict protocols limit real-world generalisability
4. Scientific publications
Peer-reviewed papers describing the evidence behind a product's ingredients or formulation. Useful for building credibility with healthcare professionals and informed consumers.
- Strengths: Independently reviewed, builds long-term credibility, supports future research
- Limitations: Publication bias toward positive results, slow process, selective reporting remains a risk
That publication bias risk isn't a minor caveat. A landmark analysis comparing 74 FDA-registered antidepressant trials against what actually appeared in the published literature found that 31% of the trials were never published at all, and that the published literature made it look like 94% of trials were positive when the FDA's own complete dataset showed the real figure was 51%. The gap wasn't random. Trials with disappointing results were the ones most likely to disappear or be reframed. If you're building a case for a nutritional product primarily on cited literature, it's worth asking not just what was published, but what else was tried and never made it into print.
5. Open-label research
Studies where both the participant and the researcher know what is being taken. More flexible than blinded designs and useful for early-phase work.
- Strengths: Easier to run, good for generating preliminary data, allows in-study adjustments
- Limitations: Placebo effects are harder to separate out, less persuasive to regulators than blinded RCTs, participant and researcher bias can influence results
6. In vitro laboratory work
Testing ingredients in controlled lab conditions before moving to human studies. Useful for understanding mechanisms and identifying potential issues early.
- Strengths: Highly controlled, fast, cost-effective for screening, avoids ethical complexities of early human exposure
- Limitations: Results do not always transfer to humans, does not account for how the body processes a product in context, usually needs to be combined with in vivo or clinical data to be persuasive
The six methods, side by side
| Method | Speed | Persuasiveness to regulators | Main risk |
|---|---|---|---|
| Consumer insights | Fast | Low | Self-report bias |
| Real-world evidence | Slow to accumulate, ongoing | Growing | Confounding, selection bias |
| RCTs | Slow | Highest | Cost, narrow population |
| Scientific publications | Slow (relies on others' work) | Moderate to high | Publication bias |
| Open-label research | Moderate | Low to moderate | Placebo and expectation effects |
| In vitro lab work | Fast | Low on its own | Doesn't always translate to humans |
Choosing your approach
No single method provides complete validation on its own. The strongest evidence base usually combines several: laboratory work to understand the mechanism, an RCT for regulatory or healthcare credibility, and RWE to demonstrate real-world performance at scale, cross-checked against the full picture of what's been tried and published, not just the studies that happened to succeed.
Where you start depends on your product category, your budget, your timeline, and the claims you need to support. Getting clear on those questions before designing a study tends to save a significant amount of time and money.